MarketCap
Amarin Corporation plc AMRN
$ 11.75
0.09%
Facebook
X
Telegram
Amarin Corporation plc ROCE Ratio | AMRN
Annual ROCE Ratio Amarin Corporation plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.53 | -18.16 | -11.81 | -16.89 | 1.51 | -2.98 | -3.79 | -47.37 | -85.84 | -72.32 | -79.1 | -44.28 | -84.7 | -40.88 | -37.49 | -162.29 | -516.05 | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.51 | -516.05 | -72.53 |
Quarterly ROCE Ratio Amarin Corporation plc
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.88 | -8.69 | -9.39 | -10.35 | -19.42 | -21.67 | -18.46 | -17.47 | -7.92 | -7.09 | -11.06 | -11.48 | -12.16 | -9.24 | -15.45 | -16.84 | -12.99 | -14.11 | -2.54 | 1.47 | 0.24 | 1.09 | 0.45 | -3.25 | -3.48 | -3.1 | -4.98 | -11.88 | -26.65 | -63.88 | -111.24 | -123.13 | -122.7 | -95.8 | -60.8 | -57.18 | -57.88 | -59.69 | -66.73 | -70.96 | -72.19 | -79.65 | -77.48 | -69.82 | -69.86 | -66.17 | -62.75 | -60.64 | -60.5 | -59.25 | -71.44 | -84.13 | -81.42 | -81.46 | -65.16 | -46.4 | -44.27 | -36.39 | -37.02 | 90.8 | -7.54 | -11.55 | 120.35 |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 120.35 | -123.13 | -35.04 |
ROCE Ratio of other stocks in the Biotechnology industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Monopar Therapeutics
MNPR
|
-12.12 | $ 71.42 | -3.16 % | $ 529 M |  USA |
 |
BridgeBio Pharma
BBIO
|
-82.04 | $ 78.67 | 0.95 % | $ 15.1 B | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
107.2 | $ 7.53 | -1.38 % | $ 1.58 B | USA |
 |
Bicycle Therapeutics plc
BCYC
|
-37.4 | $ 3.68 | -2.39 % | $ 255 M |  Britain |
 |
Coherus BioSciences
CHRS
|
-153.56 | $ 0.64 | -21.66 % | $ 75 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-4.03 | $ 27.45 | 4.77 % | $ 3.49 B | USA |
 |
Cellectis S.A.
CLLS
|
-18.48 | $ 1.12 | -0.45 % | $ 112 M |  France |
 |
BeyondSpring
BYSI
|
-213.69 | $ 0.6 | -2.21 % | $ 24.7 M | USA |
 |
Alkermes plc
ALKS
|
13.07 | $ 46.48 | 0.67 % | $ 7.66 B |  Irlanda |
 |
Altimmune
ALT
|
-42.02 | $ 1.94 | -8.51 % | $ 171 M | USA |
 |
Cardiff Oncology
CRDF
|
-107.87 | $ 0.79 | -0.77 % | $ 52.8 M | USA |
 |
Citius Pharmaceuticals
CTXR
|
-57.03 | $ 0.5 | -5.43 % | $ 5.53 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
-32.48 | $ 9.41 | -0.84 % | $ 258 M |  Israel |
 |
Arrowhead Pharmaceuticals
ARWR
|
8.53 | $ 49.04 | -0.41 % | $ 6.56 B | USA |
 |
Atara Biotherapeutics
ATRA
|
674.99 | $ 8.18 | -0.73 % | $ 103 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
5.72 | $ 16.3 | -1.93 % | $ 2.19 B |  Canada |
 |
Cullinan Management
CGEM
|
-58.85 | $ 11.34 | -3.32 % | $ 683 M | USA |
 |
BioNTech SE
BNTX
|
-7.08 | $ 87.2 | -0.36 % | $ 21.1 B |  Germany |
 |
Collegium Pharmaceutical
COLL
|
4.99 | $ 24.47 | -0.97 % | $ 775 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
-57.84 | $ 3.95 | 12.07 % | $ 52.6 M | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
-0.65 | $ 1.21 | -11.68 % | $ 55.3 M | Israel |
 |
AnaptysBio
ANAB
|
305.36 | $ 48.4 | 0.9 % | $ 1.4 B | USA |
 |
Assembly Biosciences
ASMB
|
-5.86 | $ 21.33 | -2.11 % | $ 239 M | USA |
 |
Adagene
ADAG
|
-58.67 | $ 2.02 | -4.95 % | $ 119 M |  China |
 |
Benitec Biopharma
BNTC
|
-28.92 | $ 9.31 | -5.67 % | $ 433 M | USA |
 |
Denali Therapeutics
DNLI
|
-53.07 | $ 19.85 | -2.36 % | $ 3.43 B | USA |
 |
ImmuCell Corporation
ICCC
|
4.28 | $ 10.4 | 1.76 % | $ 93.9 M | USA |
 |
Editas Medicine
EDIT
|
-114.06 | $ 2.5 | -9.09 % | $ 222 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
-38.86 | $ 31.77 | 1.23 % | $ 1.84 B | USA |
 |
Cue Biopharma
CUE
|
-100.45 | $ 18.89 | -6.21 % | $ 1.79 B | USA |
 |
Equillium
EQ
|
-82.65 | $ 1.45 | -3.33 % | $ 83.1 M | USA |
 |
Black Diamond Therapeutics
BDTX
|
9.84 | $ 1.6 | -14.05 % | $ 91 M | USA |
 |
Abeona Therapeutics
ABEO
|
-47.08 | $ 2.46 | -3.35 % | $ 130 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
8.54 | $ 18.13 | 9.85 % | $ 3.05 B | USA |
 |
Atossa Therapeutics
ATOS
|
-94.38 | $ 2.21 | 3.76 % | $ 19 M | USA |
 |
Cleveland BioLabs, Inc.
CBLI
|
-128.47 | - | -7.31 % | $ 49 M | USA |
 |
Five Prime Therapeutics, Inc.
FPRX
|
-30.01 | - | - | $ 1.77 B | USA |
 |
ADC Therapeutics SA
ADCT
|
-48.03 | $ 1.51 | -9.88 % | $ 192 M |  Schweiz |
 |
Harmony Biosciences Holdings
HRMY
|
20.45 | $ 33.57 | -0.62 % | $ 1.93 B | USA |
 |
Ardelyx
ARDX
|
-9.92 | $ 3.0 | 2.39 % | $ 723 M | USA |
 |
Akebia Therapeutics
AKBA
|
11.0 | $ 0.54 | 1.8 % | $ 139 M | USA |
 |
Alector
ALEC
|
-69.73 | $ 2.54 | 3.05 % | $ 262 M | USA |
 |
ALX Oncology Holdings
ALXO
|
-400.37 | $ 1.11 | -13.62 % | $ 59.6 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
14.49 | $ 21.39 | 0.52 % | $ 6.7 B | USA |
|
Phathom Pharmaceuticals
PHAT
|
-125.87 | $ 5.45 | 2.16 % | $ 397 M | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
-43.06 | $ 3.8 | 2.15 % | $ 728 M | Canada |
 |
Agenus
AGEN
|
7.44 | $ 7.02 | -1.82 % | $ 209 M | USA |
 |
AbCellera Biologics
ABCL
|
-16.8 | $ 12.44 | -0.52 % | $ 3.72 B | Canada |
 |
Artelo Biosciences
ARTL
|
896.54 | $ 2.14 | 2.01 % | $ 405 K | USA |